A Randomized, Double-blinded, Placebo-controlled Study to Assess the Efficacy and Safety of Omacor in Taiwanese Hypertriglyceridemic Patients
Phase of Trial: Phase III
Latest Information Update: 16 May 2014
At a glance
- Drugs Omega-3-acid ethyl esters (Primary)
- Indications Hypertriglyceridaemia
- Focus Adverse reactions; Therapeutic Use
- 09 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Apr 2013 Planned end date changed from 1 Mar 2013 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 17 Dec 2012 New trial record